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Abstract – Tick salivary proteins are promising targets for the development of anti-tick vaccines. Recently,
we described two paralogous anti-complement proteins, called Ixodes ricinus anti-complement (IRAC)
proteins I and II, that are co-expressed in tick I. ricinus salivary glands. However, our previous attempts to
immunize rabbits against IRAC via infection with recombinant Bovine herpesvirus 4 (BoHV-4) vectors
invariably failed although both recombinants expressed high levels of functional IRAC proteins in vitro. As
IRAC are soluble monovalent antigens, one of the possible explanations is that monovalent ligation of the
B-cell receptor induces receptor activation but fails to promote antigen presentation, a phenomenon that is
thought to induce a state of B-cell tolerance. In the present study, we tried to increase IRAC immunogenicity
by expressing them as oligovalent antigens. To this end, IRAC were fused to membrane anchors and
BoHV-4 vectors expressing these recombinant forms were produced. The immunization potentials of
recombinant viruses expressing either secreted or transmembrane IRAC proteins were then compared.
While the former did not induce a detectable immune response against IRAC, the latter led to high titres of
anti-IRAC antibodies that only marginally affected tick blood feeding. All together, the data presented in
this study demonstrate that the immunogenicity of a soluble antigen can be greatly improved by anchoring it
in membrane.
BoHV-4 / IRAC / tick salivary antigen / antigen valency
1. INTRODUCTION
Ticks are blood-feeding ectoparasites. Sev-
eral observations suggest that inhibition of the
host complement alternative pathway is crucial
for the achievement of tick blood feeding. First,
it has been demonstrated that the saliva of sev-
eral Ixodes species contains an inhibitor of the
alternative pathway [17, 24]. Second, the host
range of Ixodes ticks correlates with their ability
to counteract the alternative pathway of their
most common host species [16]. Third, cases
of host resistance to ticks have been described
in which the complement system is implicated
with a predominant part of the alternative path-
way [16, 24, 30].
Recently, we described two novel salivary
anti-complement protein in Ixodes ricinus ticks,
termed I. ricinus anti-complement (IRAC)
proteins I and II [4]. Both proteins inhibit the
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by mechanisms similar to the one described
for the Ixodes scapularis anti-complement pro-
tein Isac [28]. Phylogenetic analyses of IRAC
sequences together with other Isac homologues
demonstrated that ticks belonging to the
I. ricinus complex encode a family of relatively
small anti-complement molecules. Indeed, we
demonstrated that IRAC I and IRAC II are
the products of paralogous genes co-expressed
in I. ricinus salivary glands [4]. Phylogenetic
analysis revealed that IRAC I and IRAC II
sequences were undergoing diversiﬁcation by
a process of positive Darwinian selection and
we demonstrated that this diversiﬁcation
t h r o u g he v o l u t i o no fI R A CIa n dI R A CI Ih a s
led to molecules with different inhibitory activ-
ities against the complement of different host
species [25]. Based on these observations, we
made the hypothesis that IRAC I and II, like
other tick salivary glands antigens, could be
good candidates for the development of anti-
tick vaccines.
Several studies demonstrated that Bovine
herpesvirus 4 (BoHV-4) can be used as an
efﬁcient in vitro expression vector [6, 9].
BoHV-4 belongs to the Herpesviridae family,
c-herpesvirinae subfamily, Rhadinovirus genus
[31]. BoHV-4 is not associated with a speciﬁc
pathology and can be highly prevalent in the
cattle population [26]. BoHV-4 infects mono-
cytes in vivo [18]a n de xv i v o
1 and these cells
are probably the site of viral latency. Manipula-
tions of BoHV-4 genome have recently been
facilitated by cloning BoHV-4 as a Bacterial
Artiﬁcial Chromosome (BAC). Using BAC
technology, BoHV-4 recombinants expressing
functional IRAC I or II were produced [9]
and the vaccine potential of these recombinants
for IRAC immunization was tested in vivo
using the rabbit model. Surprisingly, despite
several attempts, we were not able to induce a
humoral immune response against IRAC in
vaccinated rabbits (unpublished data).
The failure to induce anti-IRAC antibodies
could have several explanations that are not
mutually exclusive. It could be the consequence
of a too low antigenic concentration or due to
the absence of rabbit T epitopes in IRAC mol-
ecules. One additional explanation could rely
on the expression of soluble IRAC as mono-
meric antigen. Indeed, it has recently been
shown that antigen-speciﬁc B cells have a
reduced ability to present monomeric antigens
compared to oligovalent forms [14]. It was sug-
gested that this phenomenon could explain the
tolerogenic properties of some monovalent anti-
gen preparations.
In the present study, we addressed the feasi-
bility to express IRAC as oligovalent antigens
on cell surface by anchoring them in mem-
brane. Firstly, IRAC I and II sequences were
fused to the transmembrane regions of vaccinia
hemagglutinin (HA) or human CD46. These
two anchors proved to be appropriate for
expression of IRAC as transmembrane fusion
proteins. BoHV-4 recombinants expressing
IRAC I and II fused to HA or CD46 sequences
were then produced using BAC cloning tech-
nology. In vitro and ex vivo infections per-
formed with these viruses demonstrated cell
surface expression of IRAC. Finally, we com-
pared the potential of BoHV-4 recombinants
expressing either soluble or membrane
anchored IRAC proteins as anti-IRAC vaccines
using the rabbit model. While the former did
not induce a detectable immune response
against IRAC, the latter led to high titers of
anti-IRAC antibodies that partially affected tick
blood feeding.
2. MATERIALS AND METHODS
2.1. Ticks and animals
I. ricinus adult ticks were obtained from the
University of Neucha ˆtel (Switzerland) Tick Rearing
Facility. Speciﬁc-pathogen-free New Zealand white
rabbits were used for the immunization studies and
challenge infestation. All experimental protocols
were approved by the Institutional Animal Care and
Use Committee of the University of Lie `ge (Belgium).
2.2. Viruses and cell lines
Madin–Darby bovine kidney (MDBK, ATCC
CCL-22), EBL NLS-Cre cells [9]a n dC r a n d e l l –
Reese feline kidney cells (CRFK, ATCC CCL-94)
1 Dewals B., unpublished results.
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Invitrogen, Carlsbald, USA) containing 10% heat-
inactivated fetal calf serum (v/v) (FCS, Lonza, Basel,
Switzerland). The BoHV-4 V. test strain was used
throughout this study.
2.3. Construction of plasmids encoding
membrane anchored forms of IRAC
IRAC I and II open reading frames (ORF) with
exception of the stop codon were ampliﬁed by
P C Ru s i n gI R A CIo rI Is t a r tp r i m e r sa n dI R A CI
or II D stop primers, respectively (Tab. I). The PCR
products were then digested with BamHI and XhoI
and inserted into the pcDNA
TM4/TO vector (Invitro-
gen, Carlsbald, USA) opened by the same enzymes,
resulting in pcDNA
TM4/TO IRAC I D stop and
pcDNA
TM4/TO IRAC II D stop. Membrane anchor-
ing regions and stop codon were ampliﬁed from
Vaccinia HA (TMHA) (GenBank AY243312,
amino-acid residues 274 to 315) and human CD46
(TMCD46) (GenBank NM_172361, amino-acid
residues 294 to 355) using the primers listed in Table
I. PCR products were then digested with SacII and
XhoI and inserted into pcDNA
TM4/TO IRAC I D stop
and pcDNA
TM4/TO IRAC II D stop opened by the
same enzymes, resulting in pcDNA
TM4/TO IRAC I
HA, pcDNA
TM4/TO IRAC I CD46, pcDNA
TM4/TO
IRAC II HA, and pcDNA
TM4/TO IRAC II CD46.
2.4. Viral mutagenesis
Mutagenesis of wild-type V. test BAC G plasmid
[9] was performed by a two-step mutagenesis proce-
dure in bacteria using the shuttle plasmid
pST76KSR-lacZ [9]. Expression cassettes were
inserted in the far right BstE I Is i t eo fB o H V - 4
L-DNA (Fig. 1A) as performed before for cassettes
encoding soluble forms of IRAC proteins [9].
Plasmids to induce homologous recombination were
constructed as follows. PcDNA
TM4/TO IRAC I HA,
pcDNA
TM4/TO IRAC I CD46, pcDNA
TM4/TO IRAC
II HA and pcDNA
TM4/TO IRAC II CD46 were
digested with PmeI and the appropriate fragments
were inserted into the pST76KSR-lacZ IRAC I or
II digested with PmeI, resulting in pST76KSR-lacZ
IRAC I HA, I CD46, II HA, II CD46.
2.5. Southern blotting
Southern blot analysis was performed as
described previously [20].
2.6. Antibodies
Monoclonal antibodies (mAbs) directed against
rabbit CD11b (198), IgM (NRBM) and CD5
(KEN-5) were purchased from Serotec (Oxford,
UK) and used according to the manufacturer recom-
mendations. Anti-IRAC I and anti-IRAC II mAbs [4]
were also used in this study.
2.7. Indirect immunoﬂuorescent staining
of adherent cells
MDBK infected cells and CRFK transfected cells
were ﬁxed in PBS containing 4% (w/v) paraformalde-
hyde (Sigma-Aldrich, St. Louis, USA) for 10 min on
ice and then for 20 min at 20 C. After washing with
PBS, samples were permeabilized in PBS containing
0.1% (w/v) NP-40 (Sigma-Aldrich) at 37 Cf o r
10 min. Immunoﬂuorescent staining (incubation and
washes) was performed in PBS containing 10% FCS
(v/v). Samples were incubated at 37 C for 45 min
Table I. Primers used in this study.
Primer name Sequence
IRAC I start 50-AAAACGGATCCATGAAGACTGCGCTGACC-30a
IRAC I D stop 50-AAACTCGAGCCGCGGTGGGATGGCCTCAGG-30
IRAC II start 50-AAAACGGATCCATGAGGACTGCGCTGACC-30
IRAC II D stop 50-AAACTCGAGCCGCGGGGCGATGGCCTCAAG-30
TMHA start 50-TCATCCGCGGACCAAGGACTTTGTAGAAA-30
TMHA stop 50-TTCTCGAGCTAGACTTTGTTCTCTGTTTTG-30
TMCD46 start 50-GCCGCGGATACTTGACAGTTTGGATGTTTG-30
TMCD46 stop 50-AAAACTCGAGTCAGCCTCTCTGCTCTGC-30
a Bold: BamHI, italic: XhoI, italic and underlined: SacII.
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Page 4 of 13 (page number not for citation purpose)with different mAbs (Figs. 2–4) or dilutions of rabbit
serum (Fig. 5).Afterthreewashes,sampleswereincu-
bated at 37 C for 30 min with Alexa Fluor 488 goat
anti-mouse (GAM) IgG (2 lg/mL; Invitrogen) or
Alexa Fluor 488 goat anti-rabbit IgG (2 lg/mL;
Invitrogen).
2.8. Peripheral blood mononuclear cells
isolation and staining
Peripheral blood mononuclear cells (PBMC) were
prepared as described elsewhere [11]. Cells were
washed extensively with PBS before use. Immuno-
ﬂuorescent labeling was performed in PBS contain-
ing 10% FCS. For cell phenotyping, living cells
were incubated on ice for 30 min with the mAbs
described above as the primary antibody. Samples
were then washed with PBS and incubated on
ice for 20 min with Alexa Fluor 633 conjugated
goat anti-mouse IgG (H + L) (Alexa 633-GAM,
5 lg/mL; Invitrogen) as the secondary antibody.
2.9. Microscopy analysis
Epiﬂuorescent microscopy analysis was per-
formed with a DMIRBE microscope (Leica, Wetzlar,
Germany) equipped with a DC 300F CCD camera
(Leica) as described previously [5].
2.10. Flow cytometry
Flow cytometry acquisitions and analyses were
performed using a three-laser Becton Dickinson ﬂuo-
rescence-activated cell sorter (FACSAria) [10]
(Becton Dickinson, Erembodeghem, Belgium).
2.11. Immunization
Five groups, each consisting of two rabbits, were
used in this study. Animals from the different groups
were injected intravenously 2 times at one month
interval with 10
8 PFU of BoHV-4 V. test WT, V. test
BAC G IRAC I, V. test BAC G IRAC II, V. test BAC
G IRAC I HA or V. test BAC G IRAC II HA excised
recombinant strains.
2.12. Anti complement alternative pathway
assay
The property of IRAC molecules to inhibit the
alternative pathway of the rabbit complement system
was tested using the AH50 assay as described previ-
ously [9]. This assay relied on the lysis of unsensitized
human erythrocytes by diluted rabbit serum in condi-
tions that prevent activation of the classical pathway.
Brieﬂy, MDBK cells grown in 75 cm
2 ﬂask were
infected at a MOI of 1 PFU/cell with BoHV-4 V. test,
V. test BAC G IRAC I Excised and V. test BAC G
IRAC II Excised strains. Forty-eight hours after infec-
tion, cell culture supernatants were collected and
concentrated. The property of concentrated cell super-
natants to inhibit the complement alternative pathway
wasassayedbyadditionofvariousamountsofconcen-
trated cell supernatant to the test.
2.13. Challenge infestation
Four weeks after the second immunization, vacci-
nated and control rabbits were infested with 16
I. ricinus adult couples per rabbit. Ticks were con-
ﬁned in plastic capsule glued with a beewax/colo-
phane mixture on the shaven back [21]. Animals
Figure 1. Production and characterization of BoHV-4 recombinant strains expressing membrane anchored
recombinant forms of IRAC I and IRAC II. (A) IRAC I CD46, -I HA, -II CD46 or -II HA expression
cassette were inserted in the BstEII site of the V. test BAC G plasmid corresponding to the far left BstEII
site of BoHV-4 L-DNA. The insertion was performed by mutagenesis of the V. test BAC G plasmid in
bacteria through homologous recombination with pST76KSR-lacZ IRAC I HA, -I CD46, -II HA or
-II CD46 plasmids. (B and C) Characterization of BoHV-4 recombinant strains expressing membrane
anchored IRAC by a combined restriction endonuclease-Southern blot approach. The DNA of the modiﬁed
BAC plasmids generated in bacteria or from the reconstituted viral strains were analysed by HindIII
restriction (B and C, left panels) and further tested by Southern blot using IRAC I ORF (B, middle panel),
IRAC II ORF (B, right panel), human CD46 ORF (C, middle panel) and Vaccinia HA ORF (C, right panel)
as probes. Arrows indicate the restriction fragments containing IRAC ORF. Marker sizes (MS) in kb are
indicated on the left.
b
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(page number not for citation purpose) Page 5 of 13were monitored two times per day for signs of dis-
comfort or skin lesions, and ticks were counted and
examined for attachment. The unattached ticks were
counted and removed 24 h after infestation, and
detached engorged ticks were collected daily from
each rabbit, counted and weighted. The engorged
Figure 2. Characterization of membrane anchored recombinant forms of IRAC I and IRAC II. CRFK cells
were transfected with pcDNA
TM4/TO derived vectors encoding the different membrane anchored
recombinant forms of IRAC. After 18 h, cells were ﬁxed and permeabilized (panels (i) to (iii) and (vii)
to (ix)) or only ﬁxed (panels (iv) to (vi) and (x) to (xii)), then treated as described in the methods for indirect
immunoﬂuorescent labeling. mAbs anti-IRAC I or II were used as primary antibodies and were revealed by
Alexa488-GAM secondary antibody. The side of each panel corresponds to 30 lm of the specimen. (For a
color version of this ﬁgure, please consult www.vetres.org.)
Vet. Res. (2009) 40:51 L. Gillet et al.
Page 6 of 13 (page number not for citation purpose)ticks were held in a humidity chamber (25 C; 85%
of humidity) for 40 days to evaluate oviposition.
2.14. Statistical analysis
Logrank test was used for statistical analysis of
data using the program GraphPadPrism 4 (Prism soft-
ware, Irvine, USA). Statistical signiﬁcance was deter-
mined at p <0 . 0 5 .
3. RESULTS
3.1. Expression of IRAC proteins as membrane
anchored recombinant forms
To express IRAC as oligovalent antigens on
the surface of expressing cells, we anchored
them in membrane by fusing their C-terminal
end to the membrane anchoring regions of
Figure 3. Immunodetection of IRAC expressed by BoHV-4 recombinant strains. MDBK cells were
infected at a MOI of 0.01 PFU/cell with BoHV-4 V. test IRAC I (i) and (iv), BoHV-4 V. test IRAC II
(vii) and (x), BoHV-4 V. test BAC G IRAC I CD46 (ii) and (v), V. test BAC G IRAC I HA (iii) and (vi),
V. test BAC G IRAC II CD46 (viii) and (xi) and V. test BAC G IRAC II HA (ix) and (xii) excised strains.
After 48 h, cells were ﬁxed and permeabilized (panels (i–iii) and (vii–ix)) or only ﬁxed (panels (iv–vi) and
(x–xii)), then treated as described in the methods for indirect immunoﬂuorescent labeling. mAbs anti-IRAC
I or II were used as primary antibodies and were revealed by Alexa488-GAM secondary antibodies. The
side of each panel corresponds to 500 lm of the specimen.
Immunization against tick salivary antigens Vet. Res. (2009) 40:51
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and methods. Two types of anchoring regions
were tested: (i) the transmembrane domains of
human CD46, hereafter called ‘‘CD46’’ anchor,
and (ii) the transmembrane domains of Vaccinia
virus WR strain HA, hereafter called ‘‘HA’’
anchor. Immunoﬂuorescent staining of cells
transfected with the different plasmids revealed
that all recombinant proteins were associated
with cell membranes (Fig. 2). Immunoﬂuores-
centstainingofﬁxedcellsrevealedthatindepen-
dently of the kind of anchor, all recombinants
proteins were expressed on the cell surface
(Fig. 2, panels (iv–vi) and panels (ix–xii)).
3.2. Production and characterization of BoHV-4
recombinant strains expressing membrane
anchored forms of IRAC I and IRAC II
In order to test in vivo the potential of the
IRAC membrane anchored forms described
above as antigen candidates, we produced
BoHV-4 recombinant strains expressing IRAC
I CD46, -I HA, -II CD46 or -II HA under con-
trol of the hCMV IE promoter. The V. test BAC
G plasmid was used as parental background.
Resulting modiﬁed plasmids, called V. test
BAC G IRAC I CD46, -I HA, -II CD46 or
-II HA plasmids were checked by a combined
Figure 4. Membrane anchored forms of IRAC proteins are detectable at the surface of PBMC infected
ex vivo. Rabbit PBMC were collected as described in the methods and infected at a MOI of 1 PFU/cell with
BoHV-4 V. test BAC G IRAC I CD46, V. test BAC G IRAC I HA, V. test BAC G IRAC II CD46 or V. test
BAC G IRAC II HA strains. After 48 h, cells were treated as described in the methods for indirect
immunoﬂuorescent labeling with mAbs directed against rabbit CD11b, rabbit IgMs (a-B) or rabbit CD5
(a-T) and then analyzed by ﬂow cytometry for eGFP and Alexa-633 ﬂuorescences.
Vet. Res. (2009) 40:51 L. Gillet et al.
Page 8 of 13 (page number not for citation purpose)Figure 5. Infection by BoHV-4 strains expressing membrane anchored forms of IRAC elicits antibody
response against IRAC. (a) Titres of anti-BoHV-4, anti-IRAC I and anti-IRAC II antibodies in sera from the
two individual rabbits per group infected with the V. test strain of BoHV-4 or with the recombinant BoHV-4
V.testIRAC I,-IRAC II,-IRAC IHA or-IRAC IIHA excised strains.Titres wereevaluated foranti-BoHV-4,
anti-IRAC I or anti-IRAC II antibodies by indirect immunoﬂuorescent staining of CRFK cells transfected
with plasmids expressing soluble WT IRAC. Serum titres are expressed as the reciprocal of the highest
dilution of the serum that gave a positive signal on immunoﬂuorescence (equivalent data were obtained in
another experiment). (b) The ability of IRAC I and IRAC II to inhibit the complement alternative pathway of
rabbit was tested using the AH50 assay as described in the methods. The data are expressed as the percentage
of lysis observed when mock-infected concentrated cell supernatant was added to the test. (c) Effect of IRAC
immunization on tick feeding. Female ticks were fed on vaccinated rabbits one month after the second
immunization. Infested rabbits were checked daily. Anchored and detached ticks were counted. The number
of anchored ticks (expressed as a percentage of the whole population) was plotted.
Immunization against tick salivary antigens Vet. Res. (2009) 40:51
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approach (Figs. 1B and 1C), sequences of these
plasmids were further conﬁrmed by sequencing
of the regions used to target recombination
(data not shown). V. test BAC G IRAC I
CD46, -I HA, -II CD46 and -II HA plasmids
were then transfected into permissive EBL cells
to reconstitute BoHV-4 V. test BAC G IRAC I
CD46, -I HA, -II CD46 and -II HA recombi-
nant strains, respectively. The molecular struc-
ture of the four recombinant strains was
checked using the combined HindIII restriction
endonuclease-Southern blot approach described
above (Figs. 1B and 2C). The latter viruses
were grown in EBL NLS-Cre to generate
BoHV-4 V. test BAC G IRAC I CD46,
-I HA, -II CD46 and -II HA excised strains in
which the BAC cassette had been deleted.
Knowing that the recombinants had the correct
molecular structure, IRAC expression was
tested (Fig. 3). Immunoﬂuorescent staining of
MDBK cells infected by BoHV-4 V. test BAC
G IRAC I CD46, -I HA, -II CD46 and -II
HA excised strains revealed that transgenes
were expressed during the viral replication
cycle at comparable levels to the ones observed
for the recombinant viruses expressing secreted
WT forms as shown on ﬁxed and permeabilized
cells. Staining of ﬁxed cells demonstrated that
IRAC membrane anchored forms were detect-
able at the surface of infected cells (Fig. 3, pan-
els (v, vi, xi, xii)).
3.3. Membrane anchored forms of IRAC
proteins are detectable at the surface
of PBMC infected ex vivo
As BoHV-4 infects monocytes, we tested
ex vivo whether infection of these cells with
the different BoHV-4 recombinant strains
described above leads to expression of IRAC
proteins on the surface of infected cells. Detec-
tion of eGFP revealed that the tropism of
BoHV-4 amongst PBMC is restricted to mono-
cytes (Fig. 4, a-CD11b panels). Interestingly,
immunoﬂuorescent staining of IRAC proteins
demonstrated that eGFP positive cells also
expressed IRAC I or II proteins on their surface.
No speciﬁc ﬂuorescence was detectable with
WT infected cells (data not shown). Among
IRAC expressing cells, a proportion was nega-
tive for eGFP expression. This could be due to
competition between the two hCMV promoters
or due to differences in the sensitivity of the
detection.
3.4. Infection by BoHV-4 strains expressing
membrane anchored forms but not soluble
forms of IRAC elicits anti-IRAC antibody
response
Five groups consisting of two female New
Zealand white rabbits were inoculated with
BoHV-4 V. test WT or V. test BAC G IRAC
I, V. test BAC G IRAC II, V. test BAC G IRAC
IH Ao rV .t e s tB A CGI R A CI IH Ae x c i s e d
recombinant strains. None of the animals devel-
oped fever or other clinical signs during the
course of the experiment. Blood samples were
collected one month after the second immuniza-
tion and tested for anti-BoHV-4 and anti-IRAC
Io rI Ia n t i b o d i e s( Fig. 5A). All animals
developed a comparable humoral immune
response against BoHV-4 (Fig. 5A). While
animals immunized with WT BoHV-4 or with
BoHV-4 recombinants expressing soluble
IRAC did not produced detectable anti-IRAC
antibodies; rabbits infected with BoHV-4
recombinants expressing membrane anchored
forms produced high titres of anti-IRAC spe-
ciﬁc antibodies (Fig. 5A). Interestingly, despite
the relatively close homology existing between
IRAC I and IRAC II (IRAC I and IRAC II
amino-acid sequences are 66% identical), no
cross-reactivity was detected between anti-
IRAC I and anti-IRAC II sera.
3.5. Infection by BoHV-4 strains expressing
membrane anchored forms of IRAC elicits
an antibody response that does not affect
markedly the blood feeding of adult ticks
To determine if IRAC immunization could
interfere with the tick feeding process on rabbit,
weﬁrstinvestigatedthepropertyofbothproteins
to inhibit the alternative pathway of the rabbit
complement (Fig. 5B) and then immunized ani-
malswerechallengedonemonthafterthesecond
immunization with adult female I. ricinus ticks
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ﬁrst examined during the initial 24 h. No differ-
ence could be detected between the three groups
wherenearlyallticksattached.Bloodmealdura-
tions were also compared between the three
groups. On control rabbits, ticks accomplished
their blood meal within 7–10 days. However,
on BoHV-4 IRAC I HA and BoHV-4 IRAC II
HA excised infected rabbits, ticks accomplished
their blood meal within 8–12 days and 8–19
days, respectively (Fig. 5C). On BoHV-4 IRAC
II HA excised vaccinatedrabbits, 13.8%of ticks
needed between 11 and 19 days to complete
feeding and detach. On average, the blood meal
duration was increased by approximately
1.5 day on BoHV-4 IRAC II HA excised
infected rabbits (10.17 ± 2.81 days) as
compared to controls (8.74 ± 1.15 days)
(p < 0.05).Therewasnostatisticalweightdiffer-
ence detected between ticks from vaccinated or
control rabbits (data not shown) and no differ-
ence in oviposition was monitored (data not
shown). Finally, no difference in skin alteration
at the feeding site was observed between vacci-
nated and control rabbits during the challenge
andaftertheinfestationperiod (data notshown).
4. DISCUSSION
Most attempts to develop protective vac-
cines against pathogens transmitted by ticks
have met with little success [27]. The immuno-
modulatory molecules expressed in tick saliva
could explain why these parasites transmit so
many pathogens but also why vaccination
against transmitted pathogens is hardly effective
[22]. Vaccination against salivary immunomod-
ulatory molecules could not only decrease the
ﬁtness of the arthropod but also protect the host
from identiﬁed or unidentiﬁed tick transmitted
pathogens. Recently, we cloned two different
anti-complement proteins from the transcrip-
tome of I. ricinus salivary glands [4] called
IRAC I and II. Recombinant BoHV-4 vectors
expressing these proteins were produced, how-
ever, our attempts to immunize rabbits against
IRAC with these viruses invariably failed. In
the present study, we produced BoHV-4 recom-
binants expressing membrane anchored forms
of IRAC. Rabbit immunization with these
recombinant viruses led to good antibody titres
against IRAC I or II, however these antibodies
only marginally affected tick blood feeding.
The theoretical framework used to describe
the induction of humoral immune response is
based on the ‘‘two signal model of lympho-
cyte activation’’ [1] that Bretsher and Cohn
described more than 30 years ago [2]. Accord-
ing to this model, B-cell activation requires two
signals. Signal one is provided by antigen
binding to speciﬁc B-cell receptor, the second
signal occurs when a primed antigen-speciﬁc
CD4 + T cell engages with the antigen-speciﬁc
B-cell through TCR/MHC interaction. Many
studies have been dedicated to understanding
this highly complex process. Some of them
directly compared monovalent and oligovalent
antigens in their efﬁciency to activate B-lym-
phocytes [14]. Their results suggest that oligo-
meric antigens are better than monomers to
induce a humoral response. These observations
hypothesis ﬁt with the fact that intravenous
administration of soluble antigens is often used
to induce B-cell tolerance [7, 8].
Consistent with these observations and the
model described above, we observed that
immunization with BoHV-4 recombinants
expressing transmembrane forms of IRAC led
to a strong antibody response in rabbits contrary
to viruses expressing soluble forms (Fig. 5A).
This antibody response prolonged the feeding
process of ticks signiﬁcantly (Fig. 5C) but did
not affect tick engorgement or oviposition rate.
Lengthening of blood feeding is considered as
the consequence of blood feeding disturbance
by the host immune system and is therefore
often seen as a positive result in tick vaccina-
tion. However, anti-tick vaccines need to induce
rapid tick rejection in order to reduce transmis-
sion of tick-borne pathogens. From this point of
view, vaccination against single IRAC mole-
cules did not give better results than the ones
obtained previously with other tick salivary
a n t i g e n su s e ds e p a r a t e l y[ 12, 13, 23].
Different hypothesis could explain the fail-
ure of the anti-IRAC immune response to inter-
rupt the blood feeding process (Figs. 5B and
5C). Firstly, it is possible that the titre of the
anti-IRAC antibodies produced is not high
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not appropriate. Secondly, it is possible that
efﬁcient reject of the tick requires an immune
response raised against both IRAC and eventu-
ally phylogenetically related molecules. Very
recently, a group of 5 sequences homologous
to IRAC was reported in I. ricinus [3]. When
analysed with IRAC, the 5 new sequences
(termed IxAC-B1 to 5) segregated into a rela-
tively distant phylogenic group exhibiting
around 40% amino-acid identity with the for-
mer sequences. IxAC-Bs like IRAC inhibit
the alternative pathway of the complement
system. These new sequences were shown
to evolve, as we reported earlier for IRAC
[4], by positive Darwinian selection. Couvreur
et al. concluded that diversiﬁcation of these
sequences was associated with differences in
antigenicity [3] based on the relatively low
cross-reactivity of the sera raised against the
different members. This hypothesis suggests
that tick vaccination using IRAC homologues
should involve several members covering the
antigenic diversity of this anti-complement
inhibitory protein family. Thirdly, one could
postulate that efﬁcient anti-tick vaccines should
rely on several salivary antigens involved in the
inhibition of different host physiological pro-
cesses. To this end, some groups have identiﬁed
the sialotranscriptome for different tick species
[15, 19, 29]. These resources can now be used
to identify other proteins with immunomodula-
tory activities that could be used as candidate
antigens.
All together, the data presented in this study
demonstrate that BoHV-4 has a potential as an
in vivo expression vector. More importantly,
the present study demonstrates that the immu-
nogenicity of a soluble antigen can be greatly
improved by anchoring it in membrane. In the
future, this approach could be applied to other
soluble antigens for which preliminary immuni-
zation attempts failed.
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